Hsbc Holdings PLC Abbott Laboratories Call Options Transaction History

Hsbc Holdings PLC

$160 Billion
Q2 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 12, 2024	SELL	$90.19 - $110.4 $360,760 - $441,600	-4,000 Reduced 50.0%	4,000 $440,000
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $200,613 - $240,702	-2,100 Reduced 20.79%	8,000 $774,000
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $2.95 Million - $3.29 Million	-29,300 Reduced 74.37%	10,100 $1.1 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $8.17 Million - $9.62 Million	-84,400 Reduced 68.17%	39,400 $3.99 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $10.7 Million - $12.5 Million	112,400 Added 985.96%	123,800 $13.6 Million
Q2 2022 Aug 11, 2022	BUY	$102.07 - $123.37 $1.13 Million - $1.37 Million	11,100 Added 3700.0%	11,400 $1.24 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $415,908 - $509,256	-3,600 Reduced 92.31%	300 $42,000
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $3.29 Million - $3.64 Million	-28,200 Reduced 87.85%	3,900 $464,000
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $4.65 Million - $6.81 Million	-74,100 Reduced 69.77%	32,100 $2.54 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $1.74 Million - $1.94 Million	-22,200 Reduced 17.29%	106,200 $9.19 Million
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $1.13 Million - $1.22 Million	13,800 Added 12.04%	128,400 $10.7 Million
Q2 2019 Aug 13, 2019	SELL	$72.88 - $85.0 $6.38 Million - $7.44 Million	-87,500 Reduced 43.3%	114,600 $9.64 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $5.2 Million - $6.29 Million	78,600 Added 63.64%	202,100 $16.2 Million
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $5.02 Million - $6.05 Million	82,500 Added 201.22%	123,500 $9.06 Million
Q2 2018 Aug 10, 2018	BUY	$57.57 - $63.54 $1.69 Million - $1.86 Million	29,300 Added 250.43%	41,000 $2.5 Million
Q1 2018 May 11, 2018	SELL	$56.27 - $63.62 $1.81 Million - $2.04 Million	-32,100 Reduced 73.29%	11,700 $697,000
Q3 2017 Nov 14, 2017	SELL	$48.06 - $53.64 $2.24 Million - $2.5 Million	-46,700 Reduced 51.6%	43,800 $2.34 Million
Q2 2017 Aug 14, 2017	BUY	N/A	90,500	90,500 $4.4 Million

Others Institutions Holding ABT

# of Institutions

3,135

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

Vanguard Group Inc Valley Forge, PA

166M
Shares

$18.7 Billion
0.34% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$14.7 Billion
0.31% of portfolio
State Street Corp Boston, MA

74.4M
Shares

$8.36 Billion
0.34% of portfolio
Capital International Investors Los Angeles, CA

71.8M
Shares

$8.07 Billion
1.57% of portfolio
Capital Research Global Investors Los Angeles, CA

57.2M
Shares

$6.43 Billion
1.34% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account